Effects of intralymphatic immunotherapy on natural killer activity in malignant melanoma patients
โ Scribed by Peter M. Moy; Sidney H. Golub; Edward Calkins; Donald L. Morton
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 594 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: Adjuvant intraportal chemotherapy has been used with a view to prevent the development of metachronous hepatic metastases following curative resection for colorectal cancer. to evaluate the effects of this therapy on systemic antitumor immunological activity, 35 colorectal cancer pat
Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder characterized by sun sensitivity, defective DNA repair, markedly increased susceptibility to skin cancer, and a variety of immunological defects, including defective natural killer (NK) cell activity. Retinoid therapy has been demonst
The ability to redefine risk factors and to predict prognosis in patients with malignant melanoma at the time they manifest nodal metastasis can be a benefit to the patient emotionally and to the physician therapeutically. A retrospective review of 1,273 patients with stage I1 malignant melanoma wa
## Abstract The influence of tumour growth on the natural killer (NK) activity of melanoma patients was examined by analysis of NK activity in ^51^ Cr release assays before and at intervals after surgical removal of localized melanoma. In patients with Stage I and II melanoma, removal of the tumour
## Abstract Natural killer (NK) activity of human peripheral blood lymphocytes (HPBL) was studied in 32 alcoholics and 15 control subjects in a 4โh chromium release assay using K562 tumor target cells. The natural killer activity of human peripheral blood lymphocytes in alcoholics was significantly